Thu. 21 Mar 2024, 7:22am ET
Benzinga
Earnings, News
Cabaletta Bio (NASDAQ:CABA) reported quarterly losses of $(0.46) per share which missed the analyst consensus estimate of $(0.39) by 17.95 percent. This is a 188.46 percent decrease over earnings of $0.52 per share from the same period last year.